Show simple item record

dc.contributor.author-
dc.date.accessioned2025-10-02T05:14:33Z
dc.date.available2025-10-02T05:14:33Z
dc.date.issued2017-09-17 10:45:27+00:00
dc.identifier.issn-
dc.identifier.uri1179-6901
dc.identifier.urihttp://digilib.fisipol.ugm.ac.id/repo/handle/15717717/35254
dc.description.abstract-
dc.format-
dc.language.isoEN
dc.publisherAdis, Springer Healthcare
dc.relation.uri['https://www.springernature.com/gp/open-research/policies/journal-policies/apc-waiver-countries', 'https://www.springer.com/journal/40268/aims-and-scope', 'https://www.springer.com/journal/40268', 'https://www.springer.com/journal/40268/submission-guidelines']
dc.rightsCC BY-NC
dc.subject['pharmacology', 'drug development', 'Therapeutics. Pharmacology', 'RM1-950']
dc.titleDrugs in R&D
dc.typeArticle
dc.identifier.oaioai:doaj.org/journal:ff54228a355043b78f22613bb6bfd4bf
dc.journal.info-


This item appears in the following Collection(s)

Show simple item record